Date: 2013-06-04
Type of information: R&D agreement
Compound: RFID solutions
Company: Cancer Curie (France) Biolog-id (France)
Therapeutic area: Cancer - Oncology
Type agreement: R&D
production
Action mechanism:
Disease:
Details: Curie-Cancer, the body responsible for developing Institut Curie\'s industry partnership activity, has concluded a partnership with Biolog-id to develop an RFID (Radio Frequency IDentification) solution for use in tracking chemotherapy bags. The collaboration aims to make it possible to comprehensively track chemotherapy preparations through the whole process, from centralized preparation to administration to patients in health care settings.
Financial terms:
Latest news:
